SEC

Goldman Sachs Got Off Easy

Lloyd Blankfein photoGoldman got to keep 100% of what it really wanted, namely the ability to cling to its claim that if did nothing wrong. 

It did acknowledge a “mistake” for not telling CDO buyers that hedge fund operator John Paulson helped booby-trap the security before it was sold. It is common for the SEC settle Wall Street cases without an admission of guilt, but is not typical for it to allow the accused party to do but at the same time admit to a “mistake.” That’s how it works when your political influence permeates the government. You get to deny wrongdoing at the same time you admit to wrongdoing.

SEC Must Ban Auto Czar Steven Rattner From Securities Industry

Rattner photoThe Securities and Exchange Commission (SEC) is reportedly considering a ban on former auto czar Steven Rattner from working in the securities industry for up to three years. Even if he gets the three years, it would be pitifully short.

Rattner oversaw the bailouts of Chrysler and GM, which were conducted to the benefit of the United Auto Workers. In the GM bailout, billions of dollars were simply stolen from bondholders and turned over to the union-controlled funds.

Report: SEC Ignored Stanford Ponzi for Eight Years

Stanford photoThe U.S. Securities and Exchange Commission suspected that the Texas-based Stanford Financial Group was a massive Ponzi scheme eight years before it took any action to shut the company down, according to a shocking 151-page report released last week by the agency's inspector general. Click here to download a 159-page pdf of the report.

From 1997 to 2005, the SEC ignored tip-offs from Stanford Financial Group insiders, numerous complaints, and four separate examinations conducted by its own employees which concluded that the Stanford Financial Group was likely a front for a fraudulent investment scheme. It wasn't until 2005 that the SEC's Fort Worth office launched a formal investigation of the firm.

Will Goldman Sachs Now End the Sanctimony?

Blankfein photoWith the SEC now charging Goldman Sachs with a billion dollar fraud, I hope CEO Lloyd Blankfein and his colleagues will end the sanctimony and indignation that has characterized their response to recent criticism of the firm, some of it coming from these quarters. The SEC charges come a day after reports surfaced that Goldman director Rajat Guptatold is under investigation for his possible role in the separate Galleon insider trading case.

We do not subscribe to the wilder conspiracy theories about Goldman, but we do have serious concerns in two areas:

SEC Rules Wal-Mart Cannot Exclude NLPC Shareholder Proposal on ObamaCare, Cap and Trade

Mike DukeThe Securities and Exchange Commission (SEC) will not allow Wal-Mart to exclude from consideration an NLPC-sponsored shareholder proposal asking for a report on the company’s lobbying priorities. Wal-Mart suddenly finds itself on the opposite side of public opinion on ObamaCare and cap and trade, after having embraced both last year.

On January 9, Wal-Mart sought to preclude a shareholder discussion of these issues by asking the SEC if it could exclude our resolution on the grounds that it “does not focus on, or implicate, a significant social policy.” Oh, really?

BP, ConocoPhillips and Caterpillar Quit Cap-and-Trade Lobby Group; PepsiCo Should Do The Same

Nooyi photoAlthough they never should have been a part of it in the first place, three major companies have exited the U.S. Climate Action Partnership (USCAP), a coalition of corporations and environmental groups. USCAP’s mission is to “quickly enact strong national legislation to require significant reductions in greenhouse gas emissions.” The House has obliged and the result, the Waxman-Markey bill, is too strong for both the Senate and the American people.

Instead of taking a principled stand against massive government intervention in the energy economy, corporate executives argued that global warming legislation was coming anyway, so it was better to be inside the room when it was negotiated. This was the same argument made by pharmaceutical companies when they threw their support behind Barack Obama’s health care plan.

Syndicate content